Intra-articular Injection Versus Normal Rehabilitation Therapy on Temporomandibular Joint Dysfunction

Launched by COPKA SONPASHAN · Mar 18, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring whether a special treatment called an Intra-articular Injection can help improve symptoms of Temporomandibular Joint Dysfunction (TMD). TMD can cause pain and discomfort in the jaw and face, making it hard to eat or talk. In this study, participants will be divided into two groups: one will receive the injection, while the other will follow standard rehabilitation therapy. The trial will last for 15 days, during which researchers will compare the results between the two groups to see if the injection offers any extra benefits.

To take part in this trial, individuals should be aged 65 to 74 and must have noticeable symptoms of TMD, which are confirmed by an X-ray. They also need to be mentally capable of giving their permission to join the study. However, those with certain serious health issues, recent joint treatments, or infections will not be eligible. This study is a great opportunity for those suffering from TMD to potentially find relief through this innovative approach.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Presence of significant temporomandibular disorder clinical symptoms.
• • Meeting the diagnostic criteria for Temporomandibular Joint Dysfunction and confirmed by X-ray examination.
• • Patients voluntarily participate in this study and provide signed informed consent.
• • Normal cognitive function
• Exclusion Criteria:
• • Rheumatic, rheumatoid, or other severe systemic diseases.
• • Infectious temporomandibular joint arthritis or joint tumors.
• • Individuals who have recently received joint injection treatment or photodynamic therapy.